portfolio | 4biocapital

NEWSROOM

Nov 9, 2023

Araris Biotech AG Announces Research Collaboration with Taiho Pharmaceutical

Aug 29, 2023

SparingVision named a ‘Fierce 15’ Company by Fierce Biotech

May 16, 2023

4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing

Dec 6, 2022

4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A

Nov 16, 2022

4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics

Oct 4, 2022

Araris Biotech Closes $24 Million Financing Round